Skip to content
Women's Health

A Nutritionist's Clinical Take on Semaglutide in 2026

A functional nutritionist's honest clinical take on semaglutide (Ozempic, Wegovy) in 2026: what the research shows, the risks, and what women really need.

Woman reviewing health results at a functional nutrition clinic consultation

By Dr. Lahana Vigliano, DCN, CCN

Let's Have the Honest Conversation Everyone's Avoiding

By now, you've heard of Ozempic. Wegovy. Mounjaro. Zepbound. GLP-1 receptor agonists have gone from diabetes management tools to the most talked-about weight loss intervention on the planet. Celebrities, influencers, your neighbor, maybe even your doctor. Everyone seems to be on them or asking about them.

And I get it. Truly. When you've been fighting your body for years, watching the scale refuse to budge no matter what you eat or how hard you exercise, the idea of a weekly injection that finally works feels like a miracle. I understand the appeal completely.

But here's what I need you to hear from me as someone who has spent years in clinical practice working with women just like you: we need to slow down and have a real conversation about what these medications are actually doing, and more importantly, what they are NOT doing.

Stubborn Weight Is a Symptom. Full Stop.

This is the hill I will always die on. Stubborn weight is not a character flaw. It is not laziness. It is not a lack of willpower. It is a symptom. Your body is sending you a signal that something deeper is going on.

When the scale won't move, your body is essentially saying one of two things: "I don't think it's safe to lose weight right now," or "I don't have the metabolic resources I need to lose weight." Those are two very different conversations that require investigation, not suppression.

What do I commonly see driving stubborn weight in the women I work with? Hormone imbalances. Thyroid dysfunction. Poor gut health. Chronic inflammation. Blood sugar dysregulation. Nutrient deficiencies. Adrenal stress. Undereating. And yes, that last one is more common than you'd ever believe.

Here is a truth that consistently shocks women who walk into our virtual clinic: the vast majority of them are not eating enough. Not even close. Their bodies have downregulated metabolism as a protective response to chronic underfueling. Appetite suppression is literally the last thing they need.

How Semaglutide Actually Works

Semaglutide mimics GLP-1, a hormone your gut naturally produces after eating. GLP-1 does several things: it delays gastric emptying (food moves through your stomach more slowly), enhances insulin secretion to help lower blood sugar, and signals to your brain that you're full. The result is reduced appetite and, in many people, meaningful weight loss.

This is why it was originally developed for type 2 diabetes management. For that specific clinical use case, there's real value here. For weight loss in the general population? The conversation gets much more complicated.

Functional nutrition supplements and hormone test results on a marble surface
Comprehensive lab testing reveals what's actually driving weight resistance. No guesswork.

What the Research Is Telling Us Now

We have more data in 2026 than we did when these drugs first exploded in popularity, and some of what we're learning should give us pause.

The Weight Returns When You Stop

Multiple studies have now confirmed what I was saying from the beginning: when people discontinue semaglutide, the majority regain most of the weight they lost. In one landmark study, participants regained approximately two-thirds of their lost weight within a year of stopping. Why? Because the root cause was never addressed.

Muscle Loss Is a Real Concern

A significant portion of the weight lost on GLP-1 medications may come from lean muscle mass, not just fat. This is a metabolic problem. Muscle is metabolically active tissue. Losing it can make long-term weight management even harder after stopping the medication.

Gut Microbiome Data Is Still Limited

As of now, we have no robust human clinical trials examining how semaglutide affects the gut microbiome long-term. For a medication that alters gut hormone signaling, this is a significant gap.

The FDA Box Warning Still Stands

Both semaglutide formulations still carry an official FDA boxed warning related to thyroid C-cell tumors, based on animal studies. The risk in humans is not yet fully understood. Gallbladder complications are also documented, likely due to slower gallbladder motility or changes in bile composition.

Who I'm Actually Worried About

I want to be clear: I am not anti-medication. I believe there are individuals, particularly those with severe obesity and related metabolic complications, for whom the benefits of semaglutide may genuinely outweigh the risks. That is a conversation to have carefully with your medical provider.

Who I'm worried about is the woman who is 20 to 30 pounds above her comfortable weight, who has been restricting calories, doing everything "right," and still can't lose weight. She's exhausted. She's frustrated. Her doctor hands her a prescription and sends her on her way. No one looked at her labs. No one assessed her thyroid, her cortisol, her estrogen, her progesterone, her gut function. No one asked what she's actually eating or how much she's sleeping. She's just been given a tool to suppress her appetite even further, when her appetite may already be part of the problem.

What Root-Cause Work Actually Looks Like

When a woman comes to Nuvitru, we start by looking for answers, not suppressing symptoms. We use comprehensive lab testing to assess what's actually happening inside her body: hormone levels, thyroid markers, nutrient status, inflammatory markers, and gut health. We examine her diet, her stress load, her sleep, her movement.

Then we build a personalized plan that may support her metabolism, help restore hormone balance, and address the actual reasons her body has been resisting weight loss. It takes time. It is not a quick fix. But the results tend to be lasting because we're working with the body, not overriding it.

My Bottom Line

GLP-1 medications are a tool. In the right clinical context, they may have a place. But they are not a substitute for understanding your body, and they are absolutely not addressing why weight loss felt impossible for you in the first place. If you go off the medication without having done that root-cause work, your body will likely return to where it was.

You deserve more than a prescription. You deserve answers.

Woman in a positive consultation with a functional nutritionist at Nuvitru Wellness
At Nuvitru, we uncover what's actually driving your symptoms, so you can build health that lasts.

Ready to Find Out What's Actually Going On?

If you're struggling with stubborn weight, low energy, hormonal symptoms, or metabolic frustration, let's talk. At Nuvitru, we specialize in helping women uncover the root causes driving their symptoms so they can build health that actually lasts.

Book your free discovery call at nuvitru.com and let's find out what your body has been trying to tell you.


This content is for educational purposes only and is not intended to provide medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or health protocol.

Dr. Lahana Vigliano

Dr. Lahana Vigliano is the CEO of Nuvitru Wellness and a board-certified clinical nutritionist passionate about helping women achieve optimal health through root-cause care. With expertise in hormone health, digestion, and metabolism, she empowers patients to uncover and address the underlying issues behind their symptoms. Dr. Vigliano earned her Doctorate in Clinical Nutrition and leads a top-rated virtual wellness practice serving women across the U.S. When she’s not guiding patients, she enjoys mentoring foster children, speaking at wellness events, and spending time with her family in Austin, Texas. Her mission is to redefine healthcare by showing women the power of food and lifestyle to transform their health.

Elements Image

Subscribe to our newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Semper neque enim rhoncus vestibulum at maecenas. Ut sociis dignissim.

Latest Articles

A Nutritionist's Clinical Take on Semaglutide in 2026

A Nutritionist's Clinical Take on Semaglutide in 2026

A functional nutritionist's honest clinical take on semaglutide (Ozempic, Wegovy) in 2026: what the research shows, the risks, and what wom...

Building Bold Faith: Spiritual Wellness and Resilience with Kelley Tyan

Building Bold Faith: Spiritual Wellness and Resilience with Kelley Tyan

Kelley Tyan shares her journey from fitness to faith, breast cancer to bestselling author, teaching women to rise with resilience and bold ...

Scaling Without Suffering: Maria Gavriel on Building Soul-Fueled Success

Scaling Without Suffering: Maria Gavriel on Building Soul-Fueled Success

Burnout survivor Maria Gavriel reveals how to build soul-fueled, six-figure success without sacrificing well-being, freedom, or family time...